Publications

5808 Results

Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: An analysis of two intergroup studies.

Authors
KS Albain;SR Green;AS Lichter;LF Hutchins;WC Wood;IC Henderson;JN Ingle;J O'Sullivan;CK Osborne;S Martino
Journal / Conference
Journal of Clinical Oncology 14(11):3009-3017
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-8814, SWOG-8897

Costs of quality-of-life research in Southwest Oncology Group trials

Authors
CM Moinpour
Journal / Conference
Journal of the National Cancer Institute Monographs 20:11-16
Year
1996
Research Committee(s)
Cancer Control

Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia.

Authors
L Pearson;CP Leith;MH Duncan;IM Chen;T McConnell;K Trinkaus;K Foucar;CL Willman
Journal / Conference
Leukemia 10:1274-1282
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007

Correlation of PML-RARa mRNA transcript type with morphology, cytogenetics and clinical parameters in actue promyelocytic leukemia.

Authors
D Viswanatha;KJ Kopecky;K Doss;C Rankin;DR Head;RE Magenis;FR Appelbaum;CL Willman
Journal / Conference
Intl Academy of Pathology Book of Abstracts :125A(#730)
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9007, SWOG-9129 (INT-0129)

Phase 3, randomized, multi-center comparison of zoladex versus surgical ovariectomy in premenopausal patients with receptor positive metastatic breast cancer.

Authors
CW Taylor;S Green;WS Dalton;S Martino;JN Ingle;NJ Robert;CK Osborne
Journal / Conference
Proc Sixth International Congress on Anti-Cancer Treatment :(#120)
Year
1996
Research Committee(s)
Breast
Study Number(s)
SWOG-8692 (INT-0075)

A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918.

Authors
VK Malviya;PY Liu;DA Goldberg;A Hantel;RV O'Toole;RW Roach;ME Conrad;DS Alberts
Journal / Conference
Anti-Cancer Drugs 7(5):527-530
Year
1996
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8918

Evaluation of topotecan in recurrent or metastatic head and neck cancer. SWOG-9305.

Authors
RE Smith;D Lew;GI Rodriguez;SA Taylor;D Schuller
Journal / Conference
American Society of Clinical Oncology 15:310(#868)
Year
1996
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9305 (CALGB-8984)

Local toxicity patterns associated with intravesical bacillus calmette-guerin. A Southwest Oncology Group study.

Authors
DL Berry;BA Blumenstein;DL Magyary;DL Lamm;ED Crawford
Journal / Conference
International Journal of Urology 3:98-100
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8216/38

Prognostic significance of DNA ploidy in Ta/T1 bladder cancer: A Southwest Oncology Group study.

Authors
RW deVere White;AD Deitch;H Tesluk;B Blumenstein;BA Lowe;AI Sagalowsky;JA Smith Jr;PF Schellhammer;TH Stanisic;HB Grossman;E Messing;JD Crissman;ED Crawford
Journal / Conference
Urologic Oncology 2:27-34
Year
1996
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8795 (INT-0094) (EST-1888)

Comparison of tumor suppressor gene inactivation in de novo and relapsed adult acute lymphoblastic leukemia (ALL).

Authors
T Tsai;S Davalath;C Rankin;F Appelbaum;DH Boldt
Journal / Conference
American Society of Clinical Oncology 15:358(#1052)
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8417/19, SWOG-9030